Ponticelli
1984
Ponticelli Regimen for Idiopathic Membranous Nephropathy
In 62 patients with idiopathic membranous nephropathy, alternating monthly methylprednisolone and a cytotoxic agent increased remission of nephrotic syndrome compared with supportive care.
Result
- Absolute difference
- 42 points
- NNT
- 3
Absolute difference and NNT are derived from the event rates.
- Subtopic
- Membranous nephropathy
- Design
- RCT, mean 31-month follow-up
- Relevance
- Supporting: context rather than must-know.
- Cited in
- KDIGO 2021 Glomerular Diseases
- Source
- Ponticelli C, et al. N Engl J Med. 1984;310(15):946-950.doi 10.1056/NEJM198404123101503
Discussion & critique
A decades-long first-line cytotoxic regimen for progressive membranous nephropathy; its toxicity drove the search for rituximab alternatives.